Corcept Therapeutics Inc (CORT)
55.96
-0.13
(-0.23%)
USD |
NASDAQ |
Nov 21, 16:00
55.96
0.00 (0.00%)
After-Hours: 20:00
Corcept Therapeutics Profit Margin (Quarterly): 25.86% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 25.86% |
| June 30, 2024 | 21.67% |
| March 31, 2024 | 18.91% |
| December 31, 2023 | 23.16% |
| September 30, 2023 | 25.39% |
| June 30, 2023 | 23.39% |
| March 31, 2023 | 15.03% |
| December 31, 2022 | 16.11% |
| September 30, 2022 | 34.02% |
| June 30, 2022 | 26.51% |
| March 31, 2022 | 24.33% |
| December 31, 2021 | 32.44% |
| September 30, 2021 | 31.70% |
| June 30, 2021 | 28.96% |
| March 31, 2021 | 29.54% |
| December 31, 2020 | 30.32% |
| September 30, 2020 | 25.05% |
| June 30, 2020 | 31.98% |
| March 31, 2020 | 32.24% |
| December 31, 2019 | 33.43% |
| September 30, 2019 | 32.32% |
| June 30, 2019 | 27.94% |
| March 31, 2019 | 28.19% |
| December 31, 2018 | 32.93% |
| September 30, 2018 | 27.54% |
| Date | Value |
|---|---|
| June 30, 2018 | 29.20% |
| March 31, 2018 | 30.28% |
| December 31, 2017 | |
| September 30, 2017 | 32.17% |
| June 30, 2017 | 35.57% |
| March 31, 2017 | 15.90% |
| December 31, 2016 | 19.31% |
| September 30, 2016 | 11.90% |
| June 30, 2016 | 4.95% |
| March 31, 2016 | -0.12% |
| December 31, 2015 | 6.41% |
| September 30, 2015 | -4.53% |
| June 30, 2015 | -16.19% |
| March 31, 2015 | -47.81% |
| December 31, 2014 | -43.21% |
| September 30, 2014 | -82.48% |
| June 30, 2014 | -129.1% |
| March 31, 2014 | -316.2% |
| December 31, 2013 | -270.3% |
| September 30, 2013 | -414.0% |
| June 30, 2013 | -629.1% |
| March 31, 2013 | -703.8% |
| December 31, 2012 | -807.8% |
| September 30, 2012 | -786.1% |
| June 30, 2012 | -868.2% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
15.03%
Minimum
Mar 2023
34.02%
Maximum
Sep 2022
26.50%
Average
26.19%
Median
Profit Margin (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 34.10% |
| Madrigal Pharmaceuticals Inc | -172.0% |
| ADMA Biologics Inc | 29.96% |
| Alnylam Pharmaceuticals Inc | -22.27% |
| Akebia Therapeutics Inc | -53.54% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 25.77% |
| Return on Assets | 21.04% |
| Return on Invested Capital | 25.77% |
| Gross Profit Margin (Quarterly) | 98.43% |
| Operating Margin (Quarterly) | 25.53% |
| Return on Net Operating Assets | 199.0% |